http://www.lsis.com/goto/r104/rss 2010-06-23T11:11:03+01:00 text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v104/%3B%97f%FB%1Cuz%7F DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/31e56f/oral_care_in_usa) has announced the addition of the "Oral Care in USA" report to their offering. Value sales in the US oral care sector declined slightly in 2009, by just under 1%. Due to the economic downturn, consumers became more value-conscious when making purchases. However, sales of value-added products, such as power toothbrushes and battery toothbrushes, saw an increase in 2009, as consumers continued to purchase products that simplified their oral hygiene routine, despite their typically higher unit prices. Americans continue to be concerned about the aesthetics of their teeth and. (…) text/html http://www.ncbi.nlm.nih.gov NCBI PubMed http://www.lsis.com/goto/v104/%3B%97f%FB%17%7F%7Ds Synopsis An approach is described to increase the deposition efficiency of silicone conditioning actives from a shampoo on colour-treated hair via liquid crystal (LC) colloidal structures, created with a high charge density cationic polymer, poly(diallyldimethyl ammonium chloride) and negatively charged surfactants. LCs are materials existing structurally between the solid crystalline and liquid phases, and several techniques, including polarized light microscopy, small angle X-Ray analysis, and differential scanning calorimetry, were used to confirm the presence of the LC structures in the shampoo formula. Silicone deposition from the LC-containing shampoo and a control shampoo was (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v104/%3B%97f%FB%14%7Dv%7D DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/813005/feminine_care_in_t) has announced the addition of the "Feminine Care in the US to 2014" report to their offering. Feminine Care in the US to 2014 This databook provides key data and information on the feminine care market in the US. This report is a comprehensive resource for market, category and segment level data including value, volume, distribution share and company & brand share. This report also provides expenditure and consumption data for the historic and forecast periods. Scope Contains information on four categories; sanitary pads, pantiliners and shields, tampons and internal (…) text/html http://www.ncbi.nlm.nih.gov NCBI PubMed http://www.lsis.com/goto/v104/%3B%97f%FD%1C%7Ex%7F Global analysis of gene expression in target cells or tissues in response to a toxicant holds significant promise for predictive toxicology. Toxicants elicit a characteristic pattern of gene expression that is dependent on mechanism of action. These mechanism-specific transcript profiles can be used as the basis for predictive toxicology. Potential applications include prioritizing chemicals for testing and customizing testing approaches based on the chemical. Results that are useful in this predictive context can be obtained from animal or in vitro models. Gene expression analysis can also be used to elucidate the shape of the dose-response curve at exposure levels below the no observed (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v104/%3B%97f%FD%11%7Exs WALTHAM, Mass.-(BUSINESS WIRE)-Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced its Central Coding ¢ application has become the first product to achieve certification by the Uppsala Monitoring Center (UMC). Launched today ( œUppsala Monitoring Centre Launches Software Certification Program for WHO Drug Dictionary Enhanced ), UMC s new certification is designed to help software developers quickly and easily integrate the WHO Drug Dictionary Enhanced. The WHO Drug Dictionary Enhanced is the world s most comprehensive dictionary of medicinal product information and the de facto standard for coding (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v104/%3B%97f%FE%1Cu%7Dz ISSY-LES-MOULINEAUX, France-(BUSINESS WIRE)-Regulatory News: Sodexo (PARIS:SW) (OTCBB:SDXAY), world leader in Quality of Daily Life solutions, and Procter & Gamble (NYSE: PG), won the prestigious EuroFM Award in the œPartners Across Borders  category. The award recognizes excellence in delivering facilities management services across Europe. Members from Sodexo and P&G attended the awards ceremony held during the European Facilities Management Conference in Madrid on June 1-2. To select the winners, the EuroFM jury took into consideration: The partnership between a corporate client and service provider The achievement of the partnership towards agreed goals The innovation introduced (…) text/html http://www.ncbi.nlm.nih.gov NCBI PubMed http://www.lsis.com/goto/v104/%3B%97f%FE%10%7E%7Ex Vicks VapoRub (Procter & Gamble, Cincinnati, OH) is one of the most popular over-the-counter therapies in the world, used to provide relief from the symptoms of the common cold and non-life-threatening respiratory infections. Even as more advanced products have come and gone, VapoRub continues to dominate the market almost 9 decades after the death of its formulator, Lunsford Richardson (Figure). |-| Skinmed. |-| Al Aboud K. |-| Dermatology Department, King Faisal Hospital, Makkah, Saudi Arabia. amoa65@hotmail.com text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v104/%3B%97g%F6%12%7Fwr STOCKHOLM & WASHINGTON-(BUSINESS WIRE)-Tobii Technology Inc., the global market leader in attention and visibility measurement technology, announced today that Procter & Gamble (NYSE:PG), the world s largest consumer goods company, has made Tobii one of its preferred partners for scaled virtual market research solutions. The agreement will also enable Tobii to collaborate with P&G on Tobii product innovations. P&G will use Tobii solutions for package and shelf testing on a global basis to increase speed to market with products that meet and exceed consumer expectations. P&G continuously evaluates and implements innovative technologies that help us leverage scale and streamline processes (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v104/%3B%97g%F6%10%7E%7B%7C PORT WASHINGTON, N.Y.-(BUSINESS WIRE)-Parker Waichman Alonso LLP announces that they have filed two lawsuits against Procter & Gamble on behalf of two women diagnosed with copper deficient neuropathy attributed to their use of Fixodent denture adhesive cream. According to their complaints, Faye G. Hobson, 45, of Sanford North Carolina, and Barbara Sue Mendenhall, 58, of Genevieve, Missouri, received dentures years ago, and both used Fixodent denture cream. Their lawsuits allege that as a result of using Fixodent, Ms. Hobson and Ms. Mendenhall now suffer from profound and permanent neurological injuries, which has left them unable to perform their normal, customary, and daily activities. (…) text/html http://www.marketwire.com Marketwire http://www.lsis.com/goto/v104/%3B%97g%F7%10xz%7C Highlighted Links Etegent Technologies ltd CINCINNATI, OH-(Marketwire - May 27, 2010) - Sheet Dynamics, Ltd, a high-tech research and development firm, today announced that it has changed its name to Etegent Technologies, Ltd. The company, which was founded in 1996 by two University of Cincinnati PhD Engineering researchers, specializes in integrated mechatronic systems design and research in physics-based data exploitation in a variety of areas, including nondestructive test data management, intelligence, surveillance and reconnaissance. Among Etegent's customers are Ball Aerospace, Emerson Electric, General Electric, Procter & Gamble, SAIC, the U.S. Air Force, and the U.S. Navy. In (…) text/html http://www.marketwire.com Marketwire http://www.lsis.com/goto/v104/%3B%97g%F8%12uz%7E Highlighted Links INSIGHT Supply Chain Solutions Supply Chain Solutions MANASSAS, VA-(Marketwire - May 25, 2010) - INSIGHT, Inc., a top international provider of supply chain planning solutions for the world's foremost companies, announces that in an age of lengthening supply chains serving globe-spanning operations, the recent volcanic eruption in Iceland is yet another example of why it is critical to identify supply chain vulnerabilities and develop mitigating strategies. The airlines lost $1.7B in revenues due to the volcanic eruption. Kenya's horticulture industry lost $12 million. A trade association in South Korea said the economic cost of lost exports was $112 million. Taiwan (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v104/%3B%97g%F8%12zx%7B DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/404887/feminine_care_in_p) has announced the addition of the "Feminine Care in Pakistan to 2014" report to their offering. This databook provides key data and information on the feminine care market in Pakistan. This report is a comprehensive resource for market, category and segment level data including value, volume, distribution share and company & brand share. This report also provides expenditure and consumption data for the historic and forecast periods. Scope of the report: Contains information on two categories; sanitary pads, pantiliners and shields. Market, category and segment level (…) text/html http://www.biospace.com BioSpace http://www.lsis.com/goto/v104/%3B%97g%F8%17%7Dwr IRVINE, CA-(Marketwire - 05/24/10) - BIOLASE Technology, Inc., the world's leading dental laser company, announced today that it has signed a license agreement with The Procter & Gamble Company (P&G) to enable BIOLASE to launch light-based oral care devices to dental professionals. Negotiations concluded late last week with the signing of the agreement at P&G headquarters in Cincinnati. BIOLASE currently plans to market the new products to professionals through its primary distribution partner Henry Schein (NASDAQ:HSIC - News) and its other distribution partners around the world. "This agreement on implementing a product launch is an important milestone in our partnership with Procter & (…) text/html http://www.ncbi.nlm.nih.gov NCBI PubMed http://www.lsis.com/goto/v104/%3B%97g%F9%12%7D%7Fx Kendrick Mass Mapping of complex sample compositions, via data derived by Fourier transform ion cyclotron resonance mass spectrometry (FTICRMS) at 1 000 000 resolution, is becoming more common. The Orbitrap mass spectrometer (Fourier Transform Axially Harmonic Orbital Trapping) also uses FT methods and indirect detection, though operating at a maximum resolution of 100 000. We define the more general case of Normalized Mass Mapping to any repeating oligomer unit (e.g., C(3)H(6)O(2) and apply it to Orbitrap-based mapping of a complex polyglycerol ester, 'green' raw material. Mass measurement errors showed sub-ppm precision and accuracy in many cases, parameters that are critical to (…) text/html http://www.ncbi.nlm.nih.gov NCBI PubMed http://www.lsis.com/goto/v104/%3B%97g%F9%13%7Fwx Abstract Dietary fiber fermentation decreases luminal pH by the production of short-chain fatty acids (SCFAs). Additional proposed physiological benefits of fiber fermentation include decreased growth of pathogenic bacteria, increased mineral absorption, and serving as an energy source for the colon epithelium. This study examined three common fiber supplements-wheat dextrin (WD) (Benefiber(R), Novartis Consumer Health Inc., Parsippany, NJ, USA), psyllium (PS) (Metamucil(R), Procter & Gamble, Cincinnati, OH, USA), and inulin (Fiber Sure(R), Procter & Gamble)-for pH, SCFAs, and gas production. An established in vitro fermentation model was used to simulate colonic fermentation at 0, (…) text/html http://www.ncbi.nlm.nih.gov NCBI PubMed http://www.lsis.com/goto/v104/%3B%97g%FD%12%7B%7Cr Background: The term "sensitive skin" is being used with increasing frequency in the scientific literature. The general perception is that sensitive skin is more of a complaint for women, with very little emphasis on what sensitive skin means to men. Hypothesis/Aims: An epidemiologic approach was used to compare gender difference with regard to perceptions about sensitive skin. Methods: The population consisted of 163 men with a mean (standard deviation [SD]) age of 38.6 (9.7) years and 869 women with a mean (SD) age of 35.1 (9.6) years. Participants filled out a questionnaire that was designed to evaluate perceptions of sensitive skin in general and at specific body sites and asked about (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v104/%3B%97g%FE%1Cuxr WALTHAM, Mass.-(BUSINESS WIRE)-Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced the latest version of the Phase Forward ¢ Clinical Development Center (CDC), a centralized solution for integrating, managing and analyzing clinical information. This new release focuses on streamlining the preparation of clinical trial data for analysis by providing a flexible and effective workflow to track, manage and reconcile data discrepancies that can be found within different data sources. Our customers are looking for a centralized solution to efficiently process the increasing amounts of data collected within clinical (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v104/%3B%97g%FE%15u%7B%7C NEW YORK-(BUSINESS WIRE)-Strategyn, Inc., an industry leader in innovation management, today announced that their client, Ethicon Endo-Surgery, was named a winner in the highly competitive Science and Medical category for its HARMONIC Blade for Orthopaedic and Spine surgery at the Edison Awards Ceremony held on April 29th at The Capitale in New York City, New York. At Strategyn, we pride ourselves on being at the forefront of innovation for our clients, and our work with Ethicon Endo-Surgery is a prime example. The Edison Awards, a peer-review honor similar to the Oscars, is voted on by roughly 2,000 members of the not-for-profit Marketing Executives Networking Group (MENG), comprised of (…) text/html http://www.biospace.com BioSpace http://www.lsis.com/goto/v104/%3B%97g%FF%11%7E%7C%7D Emeryville, CA (PRWEB) April 29, 2010 - BioSoteria, Inc., a drug safety services and education firm, will be speaking today at the 2010 Lectora User Conference, hosted by Trivantis Corporation, the leader in elearning software for authoring and content creation. BioSoteria s experience with Trivantis development tools and learning management system (LMS) to create and deliver pharmacovigilance training will be presented by Michelle Flewell, CPLP, Vice President of eLearning and Informatics at BioSoteria. Flewell will discuss how BioSoteria, a private consulting and services company with a limited development budget, has been able to produce a series of online pharmacovigilance training (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v104/%3B%97g%FF%16zw%7F WALTHAM, Mass.-(BUSINESS WIRE)-Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, will participate in four industry events in April including CDISC Interchange Europe 2010, April 26-30 at the Lancaster London Hotel in London. Building an eCRF CDASH Library A Case Study At CDISC Interchange Europe, Phase Forward representatives will lead two talks on key industry data standards and drug safety related issues: Who: Alison Sanders, Principal Clinical Design Consultant, Phase Forward What: œBuilding an eCRF CDASH Library A Case Study  When: Wednesday, April 28, 11:00 a.m. 12:30 p.m. GMT Who: Wayne Kubick, Vice President, (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v104/%3B%97g%FF%15x%7Cx DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/a9a75a/herbaltraditional) has announced the addition of the "Herbal/traditional Products in USA" report to their offering. Herbal/traditional products represents a niche but rapidly developing area of self-medication in the US. 72% of overall value sales stemmed from herbal dietary supplements in 2009, with the remainder representing herbal alternatives to allopathic OTC healthcare. Within this, herbal/traditional products are largely found in cough, cold and allergy (hay fever) remedies and digestive remedies. The Herbal/Traditional Products in USA report offers a comprehensive guide to the size and (…) text/html http://www.biospace.com BioSpace http://www.lsis.com/goto/v104/%3B%97g%FF%15%7Ew%7E Soapbox - Procter & Gamble may have exited the pharmaceutical making business but some of the talent behind its drug development continues to create in Cincinnati. Blue Ash Pharmaceuticals, a startup, is on the verge of a major breakthrough with $2 million in recently secured financing and a new heart-related drug in the final stages of FDA approval. text/html http://www.ncbi.nlm.nih.gov NCBI PubMed http://www.lsis.com/goto/v104/%3B%97g%FF%15%7Dz%7E Synopsis Coloring hair using a level 3 permanent colorant involves two processes, lightening the underlying melanin and formation of the colored chromophores inside the hair. In typical in-market products the oxidant used to achieve these changes is hydrogen peroxide buffered at pH 10 with an alkalizer such as ammonium hydroxide. A new oxidant has been developed based on the combination of ammonium carbonate, hydrogen peroxide and glycine at pH 9 that can match the lightening and color performance of the current oxidant. It has the advantage that both the carbonate and hydrogen peroxide concentrations can be changed to alter the lightening performance making it a more flexible oxidant. (…) text/html http://www.ncbi.nlm.nih.gov NCBI PubMed http://www.lsis.com/goto/v104/%3B%97g%FF%15%7D%7Fy J. Cosmet. Sci., 60, 315-321 (May/June 2009) Accepted for publication January 9, 2009. Synopsis There is a need during the development of cosmetic and skin products for simple, quantitative, noninvasive measurements of product deposition onto skin. In this article we describe INSA (in vivo skin analysis) as such a method for measuring the amount of lotion transferred to the skin from tissue products. Using Fourier transform infrared spectroscopy with an attenuated total reflectance (ATR FT-IR) sampling accessory, we were able to quantify lotion levels on the arms of subjects in minutes. |-| Int J Cosmet Sci. |-| Ebrahimpour A, Ullman AH. |-| Procter & Gamble Co., 8700 Mason-Montgomery (…) text/html http://www.ncbi.nlm.nih.gov NCBI PubMed http://www.lsis.com/goto/v104/%3B%97%60%F6%13%7Ew%7F There is a continuing need to measure and communicate reliably the UVA protection offered by commercial sunscreens. To that end, the COLIPA (European Cosmetics Trade Association) 'In Vitro Sun Protection Methods' group has developed a new in vitro method for measuring UVA protection in a standardized, reproducible manner. The method is based on in vitro UV substrate spectrophotometry and convolution of resulting absorbance data with the action spectrum for the in vivo Persistent Pigment Darkening (PPD) endpoint to provide an in vitro UVA protection factor (UVAPF) which is correlated with an in vivo measure. This method has been published as a COLIPA guideline, used currently in European (…) text/html http://www.ncbi.nlm.nih.gov NCBI PubMed http://www.lsis.com/goto/v104/%3B%97%60%FA%1Cu%7Bz For the assessment of genotoxic effects of cosmetic ingredients, a number of well-established and regulatory accepted in vitro assays are in place. A caveat to the use of these assays is their relatively low specificity and high rate of false or misleading positive results. Due to the 7th amendment to the EU Cosmetics Directive ban on in vivo genotoxicity testing for cosmetics that was enacted March 2009, it is no longer possible to conduct follow-up in vivo genotoxicity tests for cosmetic ingredients positive in in vitro genotoxicity tests to further assess the relevance of the in vitro findings. COLIPA, the European Cosmetics Association, has initiated a research programme to improve (…) text/html http://www.ncbi.nlm.nih.gov NCBI PubMed http://www.lsis.com/goto/v104/%3B%97%60%FB%10x%7Cx BACKGROUND: Tretinoin is considered the benchmark prescription topical therapy for improving fine facial wrinkles, but skin tolerance issues can affect patient compliance. In contrast, cosmetic antiwrinkle products are well tolerated but are generally presumed to be less efficacious than tretinoin. OBJECTIVES: To compare the efficacy of a cosmetic moisturizer regimen vs. a prescription regimen with 0.02% tretinoin for improving the appearance of facial wrinkles. METHODS: An 8-week, randomized, parallel-group study was conducted in 196 women with moderate to moderately severe periorbital wrinkles. Following 2 weeks washout, subjects on the cosmetic regimen (n = 99) used a sun protection (…) text/html http://www.ncbi.nlm.nih.gov NCBI PubMed http://www.lsis.com/goto/v104/%3B%97%60%FC%1Dz%7Dr The delivery of emulsified silicone oil to hydrophilic silica surfaces by mixtures of cationic polysaccharides and SDS has been studied by in situ null ellipsometry, dynamic light scattering, and turbidity measurements. The emulsion contained silicone oil droplets with a hydrodynamic radius of 18 nm, stabilized by anionic and nonionic surfactants. The investigated polysaccharides were cat-guar and cat-HEC. Both polyions have qualitatively similar adsorption and bulk properties in mixtures with surfactant and emulsion droplets, and both are able to deliver emulsion droplets to the hydrophilic silica surface under suitable conditions. However, there are important quantitative differences (…) text/html http://www.ncbi.nlm.nih.gov NCBI PubMed http://www.lsis.com/goto/v104/%3B%97%60%FC%11%7Cz%7F Young and healthy-looking skin is a feature that is universally admired and considered attractive among humans. However, as we age, skin condition deteriorates due to a variety of intrinsic and extrinsic factors determined not only by genetics and physiological health but also by behaviour and lifestyle choice. As regards the latter, cumulative, repeated exposure to solar ultraviolet radiation (UVR) is linked intrinsically to the induction of specific types of skin cancer and the expression of cutaneous damage markers responsible for the majority of the visible signs of skin ageing. Here we review empirical evidence for skin-specific effects of chronic UVR exposure and relate it to (…) text/html http://www.ncbi.nlm.nih.gov NCBI PubMed http://www.lsis.com/goto/v104/%3B%97%60%FE%14x%7Dx Staphylococcal toxic shock syndrome toxin-1 (TSST-1) is the cause of menstrual TSS associated with vaginal colonization by Staphylococcus aureus. In this pilot study, we measured TSST-1 and alpha-toxin, another exotoxin, on used tampons from four healthy women with S. aureus on tampons and two women with tampon-associated menstrual TSS. Tampons from all six women were sectioned into approximately 0.5 cm(3) pieces, some containing menstrual blood and some lacking menstrual blood. The pH of tampon sections +/- menstrual blood was neutral. S. aureus was present in tampon sections at approximately equivalent counts (total counts were 1 x 10(8) to 2 x 10(9)/tampon). TSST-1 (2-80 mug/tampon) and (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v104/%3B%97%60%FE%15%7C%7E%7B NEW YORK-(BUSINESS WIRE)-Philmore Anderson IV, CEO of Sahara Media Holdings (OTCBB: SHHD), a New York City based digital media company, today issued a letter to shareholders that outlines the near-term and long-term business strategies. Dear Fellow Shareholders: Since its founding, Sahara Media has been focused on building, developing, and investing in undervalued urban brands that offer diverse lifestyle and technology resources for the growing market of young multicultural men and women. During our 2008 capital raise with John Thomas Financial, we promised to develop a powerful, online brand for the iconic Honey Magazine, and to launch the first social network targeting a primarily (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v104/%3B%97%60%FF%1Cuv%7F DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/4cc3a7/discovery_stage_pa) has announced the addition of the "Discovery Stage Partnering Agreements in Biopharma" report to their offering. The Discovery Stage Partnering Agreements in Biopharma report provides a detailed understanding and analysis of how and why companies enter discovery stage licensing/business development and other forms of partnering arrangement. The focus of the report is on partnerships for discovery technologies and discovery stage compounds where partners have joined forces to exploit these early stage opportunities. This is the earliest stage of partnering undertaken by (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v104/%3B%97%60%FF%1Dx%7Bs WALTHAM, Mass.-(BUSINESS WIRE)-Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced that it has agreed to be acquired by Oracle for $17.00 per share in cash, representing a valuation of approximately $685 million. The transaction is subject to stockholder and regulatory approval and other customary closing conditions and is expected to close in mid-2010. Deployed in over 10,000 clinical trials, Phase Forward s software has been used successfully by hundreds of customers to accelerate innovation in drug development and patient care delivery. We look forward to combining our complementary wealth of (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v104/%3B%97%60%FF%1Dx%7F%7C ELYRIA, Ohio-(BUSINESS WIRE)-Invacare Corporation (NYSE: IVC) is pleased to introduce its new global website at www.invacare.com. This new website captures the essence of Invacare today, including the breadth of product offerings and the impact these products have on people s lives around the globe. It was only 30 years ago when Invacare had limited product lines of standard wheelchairs and patient aids, net sales of $19.5 million, 350 associates and had three plants in the United States œIt was only 30 years ago when Invacare had limited product lines of standard wheelchairs and patient aids, net sales of $19.5 million, 350 associates and had three plants in the United States,  said (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v104/%3B%97%60%FF%12z%7F%7D WALTHAM, Mass.-(BUSINESS WIRE)-Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, will host its eighth annual European Users Conference (EUC) April 21 22 at the Corinthia Hotel in Budapest, Hungary. The conference will offer a full day of industry, product and customer-led sessions. Like other sectors in healthcare, the pharmaceutical industry is in the midst of a highly transformative period Company Chairman and CEO, Bob Weiler will commence the plenary session with a welcome keynote address. Lord Robert Winston, Professor of Science and Society and Emeritus Professor of Fertility Studies at Imperial College, will deliver (…) text/html http://www.biospace.com BioSpace http://www.lsis.com/goto/v104/%3B%97%60%FF%13xz%7F Paris, April 12, 2010 The greentech company Deinove (the world's leading specialist in the application of deinococci bacteria to biofuels and green chemistry) today announced that Bruno Weymuller had accepted its invitation to join the Board of Directors. As a former Strategy Director and Director of Risk Assessment at Total, Bruno Weymuller is an acknowledged petroleum industry expert. œWe are delighted that Bruno Weymuller has agreed to join our Board of Directors, alongside other leading industrial personalities like Paul-Joël Derian (VP R&D, Rhodia), Christian Pierret (the former French Minister of Industry) and Nabil Sakkab (the former global VP R&D, Procter & Gamble). Bruno will (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v104/%3B%97%60%FF%13%7E%7Cs WALTHAM, Mass.-(BUSINESS WIRE)-Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, announced today that it will release financial results for the quarter ended March 31, 2010 and hold a conference call with investors on Tuesday, April 27, 2010. The Company plans to hold the investor conference call, hosted by Bob Weiler, chairman and chief executive officer, and Chris Menard, senior vice president and chief financial officer, to discuss its first quarter 2010 financial results and its outlook for the second quarter and full year 2010. The call will be held on Tuesday, April 27, 2010, at 5:00 p.m. (EDT). The (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v104/%3B%97%60%FF%10t%7C%7D BOSTON-(BUSINESS WIRE)-The Consumer Genetics Conference is pleased to announce speakers for its second annual meeting, to be held June 2-4 at the Hynes Convention Center in Boston. CGC(www.consumergeneticsconference.com) is a conference targeted at key issues faced by organizations and individuals trying to move genetic testing and personalized medicine downstream to the consumer level. Here are just a few highlights of the upcoming meeting: George Church, professor of genetics at Harvard Medical School and founder of the Personal Genome Project, will give a keynote on the state of the DTC genetics field. Eric Green, director of the National Human Genome Research Institute, will moderate (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v104/%3B%97%60%FF%11tv%7D WALTHAM, Mass.-(BUSINESS WIRE)-Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced that Integrium LLC, a contract research organization (CRO) specializing in dermatology, cardiovascular and metabolic disease clinical research, recently signed an agreement for the use of Phase Forward ¢ IRT. Integrium has developed a strong reputation for expertise and excellence in dermatology, cardiovascular and metabolic disease clinical trials Integrium works with specialty, development-stage, mid-size, and large biopharmaceutical and medical device companies, providing a complete range of clinical trial management (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v104/%3B%97%60%FF%11%7C%7Ez WALTHAM, Mass.-(BUSINESS WIRE)-Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, will participate in four industry events in April including CDISC Interchange Europe 2010, April 26-30 at the Lancaster London Hotel in London. Building an eCRF CDASH Library A Case Study At CDISC Interchange Europe, Phase Forward representatives will lead two talks on key industry data standards and drug safety related issues: Who: Alison Sanders, Principal Clinical Design Consultant, Phase Forward What: œBuilding an eCRF CDASH Library A Case Study  When: Wednesday, April 28, 11:00 a.m. 12:30 p.m. GMT Who: Wayne Kubick, Vice President, (…) text/html http://www.marketwire.com Marketwire http://www.lsis.com/goto/v104/%3B%97%60%FF%16%7Bv%7D Highlighted Links Subscribe to Cutting Edge Info Cutting Edge Info's Webinars DURHAM, NC-(Marketwire - March 31, 2010) - Business research firm Cutting Edge Information has launched an in-depth study focused on budgeting and management for oral care product development and clinical trials (http:/www.cuttingedgeinfo.com/surveys/oralcare/oralcare.htm). Cutting Edge Information analysts built this study's framework from the topics most important to product development executives during the development phase. "This study will allow consumer product organizations to benchmark their efforts against top performers and incorporate best practices into their departments," said Yanis Saradjian, (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v104/%3B%97%60%FF%16y%7Es -(BUSINESS WIRE)-ExpertSource: [t]echnology is a tool that helps nurses optimize patient care. It doesn't replace anything. It enables us to have data for research and with research, to change practice. TOPIC: The effort to create a Nursing Minimum Data Set, the first attempt to standardize the collection of essential nursing data across care settings, will transform nursing. That's the contention of nursing informatics expert Roy L. Simpson, RN, C, FNAP, FAAN. He is the Vice President of Cerner Group (a healthcare IT group) who spoke at a March 5 nursing technology conference at the Medical College of Georgia, as reported upon by the Atlanta Journal-Constitution. Mr. Simpson believes (…) text/html http://www.marketwire.com Marketwire http://www.lsis.com/goto/v104/%3B%97%60%FF%16%7F%7D%7F Highlighted Links imc ² Web Site imc ² Positive Impact Report DALLAS, TX-(Marketwire - March 30, 2010) - Two years after becoming the first agency to issue a GRI-compliant corporate social responsibility report, imc ² is ready to lead the marketing industry into a new era that it calls the Relationship Era. In its recently-released 2009 Positive Impact Report, the agency shares its progress addressing what it defines as marketing's fundamental sustainability challenge: the unsustainable relationships that often exist between brands and people. As in previous years, the report shares imc ²'s approach and impact related to its services, people, local communities, and environment. (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v104/%3B%97%60%FF%16%7C%7By MINNEAPOLIS-(BUSINESS WIRE)-MEDNET (www.mednetworld.com) the leader in Nationwide Health Information Network (NHIN) connectivity and Health Information Exchange (HIE) today announced the election of Michael Howe, former CEO of MinuteClinic and Arby s, Inc., as Chairman of its board of directors. Mr. Howe brings extensive health care and operational expertise to MEDNET from his MinuteClinic experience. We are very pleased to have Michael Howe as Chairman of the MEDNET Board of Directors, and look forward to his positive impact to our company, our customers and most importantly on patient care œMEDNET has great technology for rapidly building modern and standardized health information (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v104/%3B%97%60%FF%17%7B%7Dz GREAT NECK, N.Y.-(BUSINESS WIRE)-Parker Waichman Alonso LLP continues its fight on behalf of victims of zinc-containing Super PoliGrip and Fixodent denture adhesives. The Denture Cream Products Liability Multidistrict Litigation currently pending in the United States District Court for the Southern District of Florida, Miami Division, before the Honorable Judge Cecilia Altonaga (MDL No. 2051) is pushing ahead. At a status conference presided over by Judge Altonaga on Tuesday, March 22, the parties discussed the continuation of discovery and the scheduling of depositions in anticipation of the first trial, which could commence as soon as early 2011. Long-term, excessive exposure to zinc (…) text/html http://www.biospace.com BioSpace http://www.lsis.com/goto/v104/%3B%97%60%FF%14%7Dw%7F AP - MASON, Ohio The company that bought Procter & Gamble Co.'s prescription drug business has given notice it plans to close its office at a southwest Ohio facility, affecting 163 workers. text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v104/%3B%97%60%FF%15uzz ORANGEBURG, N.Y.-(BUSINESS WIRE)-EuroMed Inc. today announced the appointment of Thomas E. Gardner as president and chief executive officer. In his new role, Gardner will work to accelerate the development and commercialization of novel hydrocolloid products to benefit the wound care industry. He also will promote the growth and enduring economic value of the company for its shareholders through strategic initiatives. EuroMed is a leading designer and manufacturer of wound care management products, and one of a select few custom hydrocolloid manufacturers providing comprehensive private labeling services. Tom Gardner will be a critical asset to EuroMed in that he is a specialist in the (…) text/html http://www.biospace.com BioSpace http://www.lsis.com/goto/v104/%3B%97a%F6%16y%7D%7D Cincinnati.com - The company that bought Procter & Gamble's Mason-based pharmaceutical drug business last fall plans to close the Mason office, affecting about 250 jobs there. Drug maker Warner Chilcott plans to consolidate the work to its U.S. headquarters in Rockaway, N.J., according to an internal memo obtained by The Enquirer. Some employees will be offered jobs in Rockaway, while others will be offered severance packages, the memo said. text/html http://www.ncbi.nlm.nih.gov NCBI PubMed http://www.lsis.com/goto/v104/%3B%97a%F6%14%7C%7B%7F J Evid Based Dent Pract. |-| Gerlach RW. |-| The Procter & Gamble Company, Mason, OH. text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v104/%3B%97a%F7%1Cyvy GREAT NECK, N.Y.-(BUSINESS WIRE)-Parker Waichman Alonso LLP is pleased with Procter & Gamble's recent decision to include a caution on its Web site, http:/www.dentureliving.com/, regarding the health risks posed by excessive exposure to zinc in Fixodent denture cream. The caution was added to the Web site by Procter & Gamble with little fanfare in recent days. In addition to informing consumers that Fixodent contains zinc, the new caution states that: "Some reports suggest that excessive and prolonged zinc intake may be linked to adverse health effects." The entire text may be viewed at: http:/www.dentureliving.com/fixodent-denture-products/how-to-use-fixodent. While any new caution (…)